Salarius Pharmaceuticals (SLRX) Financials

$0.62

$-0.20 (-24.37%)

As on 05-Feb-2026 09:30EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.00	--	--	--	1.84	5.23
Cost of Revenue	0.01	0.00	0.01	0.01	0.02	0.01
Gross Profit	0.00	0.00	-0.01	-0.01	1.82	5.23
Operating Expenses	5.07	5.73	12.89	31.84	12.81	13.02
Operating Profit (EBIT)	-5.07	-5.73	-12.89	-31.84	-12.81	-7.79
Other Income	--	--	--	--	--	0.44
Profit before Tax	-5.00	-5.58	-12.54	-31.61	-12.77	-7.35
Provision for Tax	--	-5.58	-12.53	-0.23	-0.06	-0.26
Profit after Tax (Net Income)	-5.00	-5.58	-12.54	-31.61	-12.77	-7.35
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-31.61	-12.77	-7.75

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	4.25	1.51	5.29	10.38	38.72	22.16
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.74	--	0.41	1.41	0.57	0.92
Current Liabilities	1.10	1.51	1.30	4.27	2.11	2.77
Total Liabilities	7.20	3.02	6.59	14.65	40.83	24.93

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.03	0.04	0.07	0.13	10.67	9.14
Current Assets	6.06	2.99	6.52	14.52	30.16	15.80
Total Assets	7.95	3.02	6.59	14.65	40.83	24.93
Total Debt*	--	0.22	0.29	--	--	0.48
Net Current Assets	4.22	1.48	5.22	10.25	28.05	13.02

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-4.53	-12.85	-17.60	-10.20	-10.31
Cash Flow from Investing Activities	--	--	--	-1.50	-1.50	0.00
Cash from Financing Activities	--	1.06	6.64	1.99	28.30	17.69
Net Cash Inflow / Outflow	--	--	--	--	--	7.38

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-46.58	-86.45	-380.08	-1,672.38	-840.02	-1,050.32
Cash EPS ($)	--	-86.38	-379.76	-1,672.03	-838.75	-1,047.74
Adjusted Book Value ($)	--	23.44	160.22	549.45	2,547.56	3,165.60
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-70.16	-389.28	-930.97	-671.07	-1,473.05
Free Cash Flow per Share ($)	--	-70.16	-389.28	-1,010.33	-671.07	-1,473.42

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-152.54	-157.16	-128.73	-41.62	-43.61
ROE (%)	-232.24	-164.02	-160.07	-128.73	-41.94	-44.91
ROA (%)	-78.57	-116.05	-118.12	-113.93	-38.83	-37.87
EBIT Margin (%)	-114,018.08	--	--	--	-696.27	-145.43
Net Margin (%)	-113,076.32	--	--	--	-693.84	-129.66
Cash Profit Margin (%)	-25.56	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-75.26	--	--	-1.00	-0.65	0.51
EBIT Growth (%)	3.26	55.53	43.87	-79.31	-68.35	7.90
Net Profit Growth (%)	-0.22	55.55	60.32	-147.55	-73.66	-6.00
EPS Growth (%)	61.93	0.77	0.77	-0.99	0.20	0.79
Book Value Growth (%)	-74.09	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.02	0.00	0.00	0.00	0.00
Price / Book Value	1.13	0.08	0.00	0.00	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.52	0.37	0.43	0.53	2.28	1.40
Close Price ($)	3.67	27.60	78.00	183.60	1,486.80	2,730.00
High Price ($)	108.00	108.00	532.80	1,626.00	10,500.00	11,640.00
Low Price ($)	3.64	18.30	63.04	128.40	1,442.10	1,665.60
Market Cap ($ Cr)	4.92	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.15	0.05	--	--	0.02
Short term debt to equity ratio	--	0.15	0.05	--	--	0.02
Current Ratio	5.49	1.98	5.02	3.40	14.29	5.70
Quick Ratio	5.49	--	--	3.78	--	5.70
Interest Coverage	--	--	--	-98.53	-286.69	-2,497.80

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	73.68
Asset Turnover	0.00	--	--	--	0.06	0.27
Receivable days	--	--	--	--	765.35	269.12
Inventory Days	--	--	-58,524.67	-88,098.17	--	--
Payable days	--	63,565.68	62,889.12	120,384.97	32,338.53	96,284.88
Cash Conversion Cycle	--	--	--	--	-31,573.19	-96,015.75

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.